Additional file 1 of Long-term cost-effectiveness of health behaviour intervention to manage type 2 diabetes in Nepal

Additional file 1: Tables S1-S2, Figures S1-S5, Table S3 and Figures S6. Table S1: Consolidated Health Economic Evaluation Reporting Standards 2022statement. Table S2: Input parameters from the clinical trials for the model development. Figure S1: Markov model trace for control arm across lifetime horizons from a societal perspective. Figure S2: Markov model trace for intervention arm across lifetime horizons from a societal perspective. Figure S3: Percentage of being cost-effectiveacross different time horizons of base case analyses from both healthcare and societal perspectives. Figure S4: Cost-effectiveness plane of 10,000 Monte Carlo simulations from a healthcare perspective across multiple time horizons. Figure S5: Cost-effectiveness acceptability curverepresenting multiple horizons from a healthcare perspective. Table S3: Additional sensitivity analyses with support of literature-based data across lifetime horizons. Figure S6: Tornado analysis of ICERs in base case analysis over the lifetime horizon from a healthcare perspective.